Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 31;13(3):316-8.
doi: 10.9758/cpn.2015.13.3.316.

Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine

Seshadri Sekhar Chatterjee  1 , Sayantanava Mitra  2 , Nitu Mallik  1
Affiliations

Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine

Seshadri Sekhar Chatterjee et al. Clin Psychopharmacol Neurosci. .

Abstract

While fluoxetine (FXT) is a frequently prescribed selective serotonin reuptake inhibitor (SSRI), with few major side-effects; altered serotonergic transmissions in hypothalamic pathways might lead to a distressing, and often embarrassing, manifestation of galactorrhea by altering prolactin release in those on FXT. We report here a case of FXT-induced hyperprolactinemic galactorrhea developing late into treatment on a stable regimen, who responded well to subsequent replacement with sertraline. Based on present finding, we suggest that while SSRIs may share similar mechanisms of action, there exist individual differences in their effects on prolactin secretion pathways.

Keywords: Fluoxetine; Galactorrhea; Hyperprolactinemia; Selective serotonin reuptake inhibitors.

PubMed Disclaimer

References

    1. Bostwick JR, Guthrie SK, Ellingrod VL. Antipsychotic- induced hyperprolactinemia. Pharmacotherapy. 2009;29:64–73. doi: 10.1592/phco.29.1.64. - DOI - PubMed
    1. Nicholas L, Dawkins K, Golden RN. Psychoneuroendocrinology of depression. Prolactin. Psychiatr Clin North Am. 1998;21:341–358. doi: 10.1016/S0193-953X(05)70009-5. - DOI - PubMed
    1. Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry. 1994;165:728–733. doi: 10.1192/bjp.165.6.728. - DOI - PubMed
    1. Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, et al. A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med. 2007;37:275–278. doi: 10.2190/PM.37.3.d. - DOI - PubMed
    1. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006–1011. doi: 10.1001/archpsyc.1989.01810110048007. - DOI - PubMed